Yakira Capital Management’s Astria Therapeutics ATXS Stock Holding History

Yakira Capital Management’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-156,076	Closed	-$2.04M	–	197
2025 Q4	$2.04M	Buy	+156,076	New	+$1.86M	0.69%	42

Yakira Capital Management's ATXS Position: Q1 2026 in Review

Yakira Capital Management sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 156,076 shares — an estimated $2.04M sold.

Yakira Capital Management first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $2.04M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Yakira Capital Management reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Yakira Capital Management sold 156,076 Astria Therapeutics shares in Q1 2026, an estimated $2.04M.
Yakira Capital Management first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
Yakira Capital Management's Astria Therapeutics position peaked at $2.04M in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Yakira Capital Management's 13F filing for Q1 2026, filed 14 May 2026.